76.56 USD
▼+0.01-0.07%
盘后 76.61 -0.01%
2026-08-03
市值
$1.87B
市盈率
—
EPS
-4.65
股息率
—
52 周区间
9.10 – 77.20
成交量
1.06M
Beta
2.84
目标价
73.80
52W 低 9.1052W 高 77.20
价格走势
公司简介
Forte Biosciences, Inc. operates as a clinical-stage biopharmaceutical company in the United States. The company’s lead product candidate is the FB-102, a proprietary anti-CD122 monoclonal antibody therapeutic candidate for various autoimmune and autoimmune-related indications, such as celiac disease, vitiligo, alopecia areata, and type 1 diabetes. Forte Biosciences, Inc. is headquartered in Dallas, Texas.